Global DNA Methylation Market Size, Status and Forecast 2022-2028

DNA methylation is an epigenetic mechanism that occurs by the addition of a methyl (CH3) group to DNA, thereby often modifying the function of the genes and affecting gene expression. The most widely characterized DNA methylation process is the covalent addition of the methyl group at the 5-carbon of the cytosine ring resulting in 5-methylcytosine (5-mC), also informally known as the “fifth base” of DNA. These methyl groups project into the major groove of DNA and inhibit transcription.
According to our latest research, the global DNA Methylation market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
Global DNA Methylation Scope and Market Size
This report focuses on the global DNA Methylation status, future forecast, growth opportunity, key market and key players. The study objectives are to present the DNA Methylation development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
Segment by Type
Consumables
Instruments
Software Tools
Segment by Application
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Contract Research Organizations (CROs)
Others
By Region
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
By Company
Abcam plc
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Exact Sciences Corporation
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Merck Group
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
QIAGEN N.V.
Thermo Fisher Scientific Inc.
Active Motif, Inc.
Diagenode Diagnostics SA
EpiGentek Group Inc.
New England Biolabs, Inc.
Zymo Research Corporation